Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001769456-23-000005
Filing Date
2023-02-10
Accepted
2023-02-10 16:06:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 13G/A lexx.htm SC 13G/A 27459
  Complete submission text file 0001769456-23-000005.txt   29124
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-85256 | Film No.: 23611810
SIC: 2834 Pharmaceutical Preparations

Mailing Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110
Business Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110 617-912-4972
Invenomic Capital Management LP (Filed by) CIK: 0001769456 (see all company filings)

EIN.: 810795975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A